Literature DB >> 22087013

Assessment of work instability in spondyloarthritis: a cross-sectional study using the ankylosing spondylitis work instability scale.

Isabelle Fabreguet1, Eugénie Koumakis, Vincent Burki, Anne Durnez, Muriel Elhai, Magali Meyer, Simon Paternotte, Judith Payet, Fanny Roure, Bruno Fautrel, Maxime Dougados, Laure Gossec.   

Abstract

OBJECTIVES: Work status is an important outcome in SpA. The objective was to assess work instability and its determinants in a cohort of patients with SpA, using the AS-work instability scale (AS-WIS).
METHODS: We performed a cross-sectional monocentre study. Patients were definite SpA patients with paid work. Work instability was measured by the AS-WIS. Its determinants were assessed by correlations with SpA scores (BASDAI, BASFI and patient's global assessment) and patients with low work instability (AS-WIS score < 11) were compared with those with moderate to high instability, through backward logistic regression.
RESULTS: In all, 156 patients were assessed: mean (s.d.) age 41 (11) years, mean disease duration 15 (11) years; 71 (45.5%) were on TNF blockers. The mean AS-WIS score was 9.5 (5.5); 55 (35%) patients had moderate and 8 (5%) patients had high work instability. Correlations of the AS-WIS score with SpA scores were significant but moderate (BASDAI R = 0.42, BASFI R = 0.41, patient's global assessment R = 0.53; P < 0.0001). In multivariate analysis, high patient's global assessment was the only element associated with moderate to high work instability; demographic characteristics and treatments were not significant elements.
CONCLUSION: Work instability was found to be high and its main determinant was patient's global assessment. The predictive validity of the AS-WIS in terms of job retention should be further assessed.

Entities:  

Mesh:

Year:  2011        PMID: 22087013     DOI: 10.1093/rheumatology/ker319

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  10 in total

Review 1.  Ankylosis in ankylosing spondylitis: current concepts.

Authors:  Nigil Haroon
Journal:  Clin Rheumatol       Date:  2015-06       Impact factor: 2.980

2.  The use of anti-TNF therapy for ankylosing spondylitis in everyday rheumatology practice and the relationship to disease activity, work disability and diagnostic delay.

Authors:  C Sullivan; K Quinn; S Harney; J G Ryan
Journal:  Ir J Med Sci       Date:  2013-12-21       Impact factor: 1.568

3.  Vasoactive Intestinal Peptide in Early Spondyloarthritis: Low Serum Levels as a Potential Biomarker for Disease Severity.

Authors:  Iria V Seoane; Eva Tomero; Carmen Martínez; Rosario Garcia-Vicuña; Yasmina Juarranz; Amalia Lamana; Elena Ocón; Ana M Ortiz; Nieves Gómez-León; Isidoro González-Álvaro; Rosa P Gomariz
Journal:  J Mol Neurosci       Date:  2015-02-25       Impact factor: 3.444

4.  Improvements in workplace and household productivity with certolizumab pegol treatment in axial spondyloarthritis: results to week 96 of a phase III study.

Authors:  Désirée van der Heijde; Jürgen Braun; Martin Rudwaleit; Oana Purcaru; Arthur F Kavanaugh
Journal:  RMD Open       Date:  2018-04-09

Review 5.  Patient Burden of Axial Spondyloarthritis.

Authors:  Vibeke Strand; Jasvinder A Singh
Journal:  J Clin Rheumatol       Date:  2017-10       Impact factor: 3.517

Review 6.  Work Disability in Axial Spondyloarthritis.

Authors:  Elena Nikiphorou; Sofia Ramiro
Journal:  Curr Rheumatol Rep       Date:  2020-07-27       Impact factor: 4.592

Review 7.  Application of machine learning in the diagnosis of axial spondyloarthritis.

Authors:  Jessica A Walsh; Martin Rozycki; Esther Yi; Yujin Park
Journal:  Curr Opin Rheumatol       Date:  2019-07       Impact factor: 5.006

Review 8.  Taiwan Rheumatology Association consensus recommendations for the management of axial spondyloarthritis.

Authors:  James Cheng-Chung Wei; Chin-Hsiu Liu; Jui-Cheng Tseng; Lin-Fen Hsieh; Chun-Hsiung Chen; Hsin-Hua Chen; Hung-An Chen; Ying-Chou Chen; Chung-Tei Chou; Hsien-Tzung Liao; Yi-Chun Lin; Shue-Fen Luo; Deng-Ho Yang; Kai-Jieh Yeo; Wen-Chan Tsai
Journal:  Int J Rheum Dis       Date:  2019-11-27       Impact factor: 2.454

Review 9.  The link between ankylosing spondylitis, Crohn's disease, Klebsiella, and starch consumption.

Authors:  Taha Rashid; Clyde Wilson; Alan Ebringer
Journal:  Clin Dev Immunol       Date:  2013-05-27

10.  How do clinical and socioeconomic factors impact on work disability in early axial spondyloarthritis? Five-year data from the DESIR cohort.

Authors:  Elena Nikiphorou; Annelies Boonen; Bruno Fautrel; Pascal Richette; Robert Landewé; Désirée van der Heijde; Sofia Ramiro
Journal:  Rheumatology (Oxford)       Date:  2022-05-05       Impact factor: 7.046

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.